Blood Tests

If it feels like there’s an onslaught of information these days about how to diagnose and treat Alzheimer’s dementia, your feelings are valid. New developments and research are coming fast and furious, as academic researchers and for-profit companies race to find effective ways to diagnose Alzheimer’s as early as possible…

In the evolving landscape of the diagnosis and treatment of Alzheimer’s, updates and insights are regularly advancing. We’ve previously reported on the introduction and demise of the first breakthrough “treatment”- Aduhelm- and then on the introduction of Leqembi, the IV-administered antibody intended to slow down the pace of cognitive decline…

There’s no doubt that we have entered an era when important opportunities will exist to delay or diminish the symptoms of dementia. As we’ve been covering in agebuzz, there is now a new drug (Leqembi) available to delay impairment and decline in patients with mild cognitive impairment or the early…

As a follow-up to our previous article portending the next new drug for Alzheimer’s, the FDA has now given approval under its accelerated approval pathway to the new medication Leqembi (originally known as Lecanemab). This drug was developed to help slow down cognitive decline in those with Mild Cognitive Impairment…

Anyone who’s ever tried to get their medical record from a particular care provider, much less organize the totality of their record from a range of providers, knows that it can be a herculean task to get it all together. While agebuzz readers know from the Powerhouse Patient series by…

It’s been said that, “Cancer is not a death sentence, but rather it is a life sentence; it pushes one to live.” Those who have cancer are not only pushing to deal with the physical consequences of the disease but also with the attitudes and platitudes of others who may…